ExodusPoint Capital Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-35,087
| Closed | -$651K | – | 2106 |
|
2023
Q3 | $651K | Sell |
35,087
-106,132
| -75% | -$1.97M | 0.01% | 1101 |
|
2023
Q2 | $1.56M | Buy |
141,219
+63,661
| +82% | +$704K | 0.01% | 829 |
|
2023
Q1 | $1.04M | Sell |
77,558
-453,009
| -85% | -$6.09M | 0.01% | 1035 |
|
2022
Q4 | $6.56M | Buy |
530,567
+446,628
| +532% | +$5.52M | 0.1% | 265 |
|
2022
Q3 | $1.17M | Buy |
+83,939
| New | +$1.17M | 0.02% | 1016 |
|
2022
Q2 | – | Sell |
-34,745
| Closed | -$565K | – | 2537 |
|
2022
Q1 | $565K | Sell |
34,745
-122,918
| -78% | -$2M | 0.01% | 1396 |
|
2021
Q4 | $2.57M | Buy |
157,663
+129,030
| +451% | +$2.1M | 0.03% | 628 |
|
2021
Q3 | $425K | Buy |
28,633
+17,998
| +169% | +$267K | 0.01% | 1436 |
|
2021
Q2 | $212K | Sell |
10,635
-7,420
| -41% | -$148K | ﹤0.01% | 1879 |
|
2021
Q1 | $417K | Sell |
18,055
-874
| -5% | -$20.2K | 0.01% | 1434 |
|
2020
Q4 | $468K | Buy |
+18,929
| New | +$468K | ﹤0.01% | 1221 |
|
2020
Q3 | – | Sell |
-40,941
| Closed | -$1.96M | – | 2280 |
|
2020
Q2 | $1.96M | Buy |
+40,941
| New | +$1.96M | 0.05% | 414 |
|
2019
Q3 | – | Sell |
-3,400
| Closed | -$271K | – | 1680 |
|
2019
Q2 | $271K | Buy |
3,400
+1,604
| +89% | +$128K | 0.01% | 725 |
|
2019
Q1 | $201K | Buy |
+1,796
| New | +$201K | 0.02% | 557 |
|